A review of the use of direct oral anticoagulant use in orthotopic heart transplantation recipients

Transplant Rev (Orlando). 2018 Jul;32(3):151-156. doi: 10.1016/j.trre.2018.04.002. Epub 2018 Apr 16.

Authors

Rosaleen Boswell¹, Glen J Pearson²

Affiliations

¹ Alberta Health Services, University of Alberta Hospital, Edmonton, AB, Canada.
² University of Alberta, Faculty of Medicine & Dentistry, Department of Medicine, Division of Cardiology, Edmonton, AB, Canada; Mazankowski Alberta Heart Institute, Edmonton, AB, Canada. Electronic address: [email protected].

PMID: 29720347
DOI: 10.1016/j.trre.2018.04.002

No abstract available

Keywords: Calcineurin inhibitors; Direct oral anticoagulant; Drug interactions; Heart transplant.

Publication types

Review

MeSH terms

Administration, Oral
Anticoagulants / pharmacology*
Dabigatran / pharmacology*
Heart Transplantation*
Humans
Pyrazoles / pharmacology*
Pyridines / pharmacology*
Pyridones / pharmacology*
Rivaroxaban / pharmacology*
Thiazoles / pharmacology*
Warfarin

Substances

Anticoagulants
Pyrazoles
Pyridines
Pyridones
Thiazoles
apixaban
Warfarin
Rivaroxaban
Dabigatran
edoxaban